Author Correction: Large-scale Metabolomic Analysis Reveals Potential Biomarkers for Early Stage Coronary Atherosclerosis

Xueqin Gao,Chaofu Ke,Haixia Liu,Wei Liu,Kang Li,Bo Yu,Meng Sun

DOI: https://doi.org/10.1038/s41598-018-23331-4

IF: 4.6

2018-01-01

Scientific Reports

Abstract:A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.

What problem does this paper attempt to address?

Correction: Interpretation of Type 2 Diabetes Mellitus Relevant GC-MS Metabolomics Fingerprints by Using Random Forests

Jian-Hua Huang,Hua-Lin Xie,Jun Yan,Dong-Sheng Cao,Hong-Mei Lu,Qing-Song Xu,Yi-Zeng Liang

DOI: https://doi.org/10.1039/c6ay90023b

IF: 3.1

2016-01-01

Analytical Methods

Abstract:Correction for ‘Interpretation of type 2 diabetes mellitus relevant GC-MS metabolomics fingerprints by using random forests’ by Jian-Hua Huang et al., Anal. Methods, 2013, 5, 4883–4889.
Large-scale Metabolomic Analysis Reveals Potential Biomarkers for Early Stage Coronary Atherosclerosis

Xueqin Gao,Chaofu Ke,Haixia Liu,Wei Liu,Kang Li,Bo Yu,Meng Sun

DOI: https://doi.org/10.1038/s41598-017-12254-1

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Coronary atherosclerosis (CAS) is the pathogenesis of coronary heart disease, which is a prevalent and chronic life-threatening disease. Initially, this disease is not always detected until a patient presents with seriously vascular occlusion. Therefore, new biomarkers for appropriate and timely diagnosis of early CAS is needed for screening to initiate therapy on time. In this study, we used an untargeted metabolomics approach to identify potential biomarkers that could enable highly sensitive and specific CAS detection. Score plots from partial least-squares discriminant analysis clearly separated early-stage CAS patients from controls. Meanwhile, the levels of 24 metabolites increased greatly and those of 18 metabolites decreased markedly in early CAS patients compared with the controls, which suggested significant metabolic dysfunction in phospholipid, sphingolipid, and fatty acid metabolism in the patients. Furthermore, binary logistic regression showed that nine metabolites could be used as a combinatorial biomarker to distinguish early-stage CAS patients from controls. The panel of nine metabolites was then tested with an independent cohort of samples, which also yielded satisfactory diagnostic accuracy (AUC = 0.890). In conclusion, our findings provide insight into the pathological mechanism of early-stage CAS and also supply a combinatorial biomarker to aid clinical diagnosis of early-stage CAS.
Corrigendum: Bibliometric and Visual Analysis on Metabolomics in Coronary Artery Disease Research

Ning Yu,Ruirui Wang,Baocheng Liu,Lei Zhang

DOI: https://doi.org/10.3389/fcvm.2022.937508

IF: 3.6

2022-06-28

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2022.804463.].

cardiac & cardiovascular systems
Corrigendum: Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction

Xiaolin Zhang,Yi Cai,Xu Su,Quanmin Jing,Haiwei Liu,Kun Na,Miaohan Qiu,Xiaoxiang Tian,Dan Liu,Tianxiao Wu,Chenghui Yan,Yaling Han

DOI: https://doi.org/10.3389/fimmu.2023.1163419

IF: 7.3

2023-03-08

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.950441.].

immunology
Metabolic Biomarkers For Prognostic Prediction Of Pre-Diabetes: Results From A Longitudinal Cohort Study (Vol 7, 6575, 2017)

Hailuan Zeng,Renchao Tong,Wenxin Tong,Qiaoling Yang,Miaoyan Qiu,Aizhen Xiong,Siming Sun,Lili Ding,Hongli Zhang,Li Yang,Jingyan Tian

DOI: https://doi.org/10.1038/s41598-017-06309-6

IF: 4.6

2017-01-01

Scientific Reports

Abstract:A correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.
Author Correction: The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24)

Xue-Lian Zhang,Shen-Yuan Yuan,Gang Wan,Ming-Xia Yuan,Guang-Ran Yang,Han-Jing Fu,Liang-Xiang Zhu,Jian-Dong Zhang,Yu-Ling Li,Da-yong Gao,Xue-Li Cui,Zi-ming Wang,Rong-Rong Xie,Ying-jun Chen

DOI: https://doi.org/10.1038/s41598-021-90670-0

IF: 4.6

2021-05-20

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

multidisciplinary sciences
Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Xinyang Liu,Shukui Qin,Zhichao Wang,Jianming Xu,Jianping Xiong,Yuxian Bai,Zhehai Wang,Yan Yang,Guoping Sun,Liwei Wang,Leizhen Zheng,Nong Xu,Ying Cheng,Weijian Guo,Hao Yu,Tianshu Liu,Pagona Lagiou,Jin Li

DOI: https://doi.org/10.1186/s13045-017-0545-5

IF: 28.5

2017-01-01

Journal of Hematology & Oncology

Abstract:The original article [1] contains two errors in Table 2
Correction to: Biomarkers in clinical epidemiology studies

DOI: https://doi.org/10.1093/ckj/sfae293

2024-09-28

Abstract:[This corrects the article DOI: 10.1093/ckj/sfae130.].
Corrigendum: Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction

Xiaolin Zhang,Minghui Cheng,Naijing Gao,Yi Li,Chenghui Yan,Xiaoxiang Tian,Dan Liu,Miaohan Qiu,Xiaozeng Wang,Bo Luan,Jie Deng,Shouli Wang,Hongyan Tian,Geng Wang,Xinliang Ma,Gregg W. Stone,Yaling Han

DOI: https://doi.org/10.3389/fcvm.2022.840102

IF: 3.6

2022-02-23

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.747511.].

cardiac & cardiovascular systems
Author Correction: P66shc: A Novel Biomarker of Tubular Oxidative Injury in Patients with Diabetic Nephropathy.

Xiaoxuan Xu,Xuejing Zhu,Mingming Ma,Yachun Han,Chun Hu,Shuguang Yuan,Yuan Yang,Li Xiao,Fuyou Liu,Yashpal S Kanwar,Lin Sun

DOI: https://doi.org/10.1038/s41598-020-62787-1

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Author Correction: P66shc: A Novel Biomarker of Tubular Oxidative Injury in Patients with Diabetic Nephropathy

Xiaoxuan Xu,Xuejing Zhu,Mingming Ma,Yachun Han,Chun Hu,Shuguang Yuan,Yang Yuan,Li Xiao,Fuyou Liu,Yashpal S. Kanwar,Lin Sun

DOI: https://doi.org/10.1038/s41598-020-62787-1

IF: 4.6

2020-01-01

Scientific Reports

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Author Correction: A Comprehensive Bioinformatics Analysis on Multiple Gene Expression Omnibus Datasets of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Shanzhou Huang,Chengjun Sun,Yuchen Hou,Yunhua Tang,Zebin Zhu,Zhiheng Zhang,Yixi Zhang,Linhe Wang,Qiang Zhao,Mao-Gen Chen,Zhiyong Guo,Dongping Wang,Weiqiang Ju,Qi Zhou,Linwei Wu,Xiaoshun He

DOI: https://doi.org/10.1038/s41598-019-39022-7

IF: 4.6

2019-01-01

Scientific Reports

Abstract:A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
Correction To: Emerging Role of Lipid Metabolism Alterations in Cancer Stem Cells

Mei Yi,Junjun Li,Shengnan Chen,Jing Cai,Yuanyuan Ban,Qian Peng,Ying Zhou,Zhaoyang Zeng,Shuping Peng,Xiaoling Li,Wei Xiong,Guiyuan Li,Bo Xiang

DOI: https://doi.org/10.1186/s13046-018-0826-z

IF: 12.658

2018-01-01

Journal of Experimental & Clinical Cancer Research

Abstract:In the publication of this article [1], there is an error in the Figure caption of Figs. 2, 3 and 4. This has now been included in this correction. The authors declare that these corrections do not change the results or conclusions of this paper.
Author Correction: Pharmacokinetics, mass balance, and metabolism of [ 14 C]vicagrel, a novel irreversible P2Y 12 inhibitor in humans

Yuan-dong Zheng,Hua Zhang,Yan Zhan,Yi-cong Bian,Sheng Ma,Hai-xian Gan,Xiao-juan Lai,Yong-qiang Liu,Yan-chun Gong,Xue-fang Liu,Hong-bin Sun,Yong-guo Li,Da-fang Zhong,Li-yan Miao,Xing-xing Diao

DOI: https://doi.org/10.1038/s41401-023-01130-6

IF: 7.169

2023-08-03

Acta Pharmacologica Sinica

Abstract:Acta Pharmacologica Sinica - Author Correction: Pharmacokinetics, mass balance, and metabolism of [14C]vicagrel, a novel irreversible P2Y12 inhibitor in humans

pharmacology & pharmacy,chemistry, multidisciplinary
Corrigendum to “FUNDC1 Insufficiency Sensitizes High Fat Diet Intake-Induced Cardiac Remodeling and Contractile Anomaly Through ACSL4-mediated Ferroptosis” [metabolism 122 (september 2021) 154840]

Zhaohui Pei,Yandong Liu,Suqin Liu,Wei Jin,Yuanfei Luo,Mingming Sun,Yu Duan,Amir Ajoolabady,James R. Sowers,Yan Fang,Feng Cao,Haixia Xu,Yaguang Bi,Shuyi Wang,Jun Ren

DOI: https://doi.org/10.1016/j.metabol.2024.155918

IF: 13.934

2024-01-01

Metabolism

Abstract:The authors regret to report an error in the above-mentioned paper in Fig. 3 as reported. For oil red O staining, density rather than the area of staining was mistakenly reported while a second batch of data was inadvertently left out in the summary analysis (affecting sample size). We have updated the summary graph as shown below (with representations matching mean values), which did not affect the original conclusion. The authors sincerely express their apology for any inconvenience for the readers.
[Corrigendum] Exosomal microRNA‑4516, microRNA‑203 and SFRP1 are potential biomarkers of acute myocardial infarction

Peng Liu,Shuya Wang,Kaiyuan Li,Yang Yang,Yilong Man,Fengli Du,Lei Wang,Jing Tian,Guohai Su

DOI: https://doi.org/10.3892/mmr.2024.13289

Abstract:Subsequently to the publication of the above article, the authors have realized that, in Fig. 1A, the incorrect image was uploaded to show the ultrastructure of exos isolated from plasma and examined using transmission electron microscopy (essentially, the image in question had already appeared in an article published by the same research group in Journal of Cellular and Molecular Medicine). In addition, the '+' and '-' signs for the 'Cell lysis' experiments shown underneath the gels in Fig. 1B were incorporated the wrong way around. The revised version of Fig. 1, showing the correct image in Fig. 1A and the correct labels in Fig. 1B, is shown below. Note that the errors made in assembling this figure did not have a major impact on either the results or the conclusions reported in this paper. The authors are grateful to the Editor of Molecular Medicine Reports for allowing them this opportunity to publish a corrigendum, and apologize to the readership of the Journal for any inconvenience caused. [Molecular Medicine Reports 27: 124, 2023; DOI: 10.3892/mmr.2023.13010].
Author correction to ‘Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy’ [Acta Pharmaceutica Sinica B 11 (2021) 3508–3526]

Shuyi Wang,Jun Tao,Huaguo Chen,Machender R. Kandadi,Mingming Sun,Haixia Xu,Gary D. Lopaschuk,Yan Lu,Junmeng Zheng,Hu Peng,Jun Ren

DOI: https://doi.org/10.1016/j.apsb.2022.12.015

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2021.07.006.].
Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Mingchuang Zhu,Qingpeng Zeng,Tao Fan,Yuanyuan Lei,Feng Wang,Sufei Zheng,Xinfeng Wang,Hui Zeng,Fengwei Tan,Nan Sun,Qi Xue,Jie He

DOI: https://doi.org/10.3389/fimmu.2022.909105

IF: 7.3

2022-05-04

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783495.].

immunology
Large-scale, comprehensive plasma metabolomic analyses reveal potential biomarkers for the diagnosis of early-stage coronary atherosclerosis

Meng Sun,Wei Liu,Hao Jiang,Xiaoyan Wu,Shuo Zhang,Haixia Liu

DOI: https://doi.org/10.1016/j.cca.2024.119832

2024-08-15

Abstract:Background: Coronary atherosclerosis (CAS) is a prevalent and chronic life-threatening disease. However, the detection of CAS at an early stage is difficult because of the lack of effective noninvasive diagnostic methods. The present study aimed to characterize the plasma metabolome of early-stage CAS patients to discover metabolomic biomarkers, develop a novel metabolite-based model for accurate noninvasive diagnosis of early-stage CAS, and explore the underlying metabolic mechanisms involved. Methods: A total of 100 patients with early-stage CAS and 120 age- and sex-matched control subjects were recruited from the Chinese Han population and further randomly divided into training (n = 120) and test sets (n = 100). The metabolomic profiles of the plasma samples were analyzed by an integrated untargeted liquid chromatography-mass spectrometry approach, including two separation modes and two ionization modes. Univariate and multivariate statistical analyses were employed to identify potential biomarkers and construct an early-stage CAS diagnostic model. Results: The integrated analytical method established herein improved metabolite coverage compared with single chromatographic separation and MS ionization mode. A total of 80 metabolites were identified as potential biomarkers of early-stage CAS, and these metabolites were mainly involved in glycerophospholipid, fatty acid, sphingolipid, and amino acid metabolism. An effective diagnostic model for early-stage CAS was established, incorporating 11 metabolites and achieving areas under the receiver operating characteristic curve (AUCs) of 0.984 and 0.908 in the training and test sets, respectively. Conclusions: Our study not only successfully developed an effective noninvasive diagnostic model for identifying early-stage CAS but also provided novel insights into the pathogenesis of CAS.
Corrigendum: Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease

Weiwei Lin,Fatemeh Mousavi,Benjamin C. Blum,Christian F Heckendorf,Jarrod Moore,Noah Lampl,Mark McComb,Sergei Kotelnikov,Wenqing Yin,Nabil Rabhi,Matthew D. Layne,Dima Kozakov,Vipul C. Chitalia,Andrew Emili

DOI: https://doi.org/10.3389/fphar.2024.1376058

IF: 5.6

2024-02-10

Frontiers in Pharmacology

Abstract:This article is a correction to: Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease

pharmacology & pharmacy

Author Correction: Large-scale Metabolomic Analysis Reveals Potential Biomarkers for Early Stage Coronary Atherosclerosis

Correction: Interpretation of Type 2 Diabetes Mellitus Relevant GC-MS Metabolomics Fingerprints by Using Random Forests

Large-scale Metabolomic Analysis Reveals Potential Biomarkers for Early Stage Coronary Atherosclerosis

Corrigendum: Bibliometric and Visual Analysis on Metabolomics in Coronary Artery Disease Research

Corrigendum: Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction

Metabolic Biomarkers For Prognostic Prediction Of Pre-Diabetes: Results From A Longitudinal Cohort Study (Vol 7, 6575, 2017)

Author Correction: The effects of acarbose therapy on reductions of myocardial infarction and all-cause death in T2DM during 10-year multifactorial interventions (The Beijing Community Diabetes Study 24)

Correction To: Early Presence of Anti-Angiogenesis-related Adverse Events As a Potential Biomarker of Antitumor Efficacy in Metastatic Gastric Cancer Patients Treated with Apatinib: a Cohort Study

Correction to: Biomarkers in clinical epidemiology studies

Corrigendum: Utility of S100A12 as an Early Biomarker in Patients With ST-Segment Elevation Myocardial Infarction

Author Correction: P66shc: A Novel Biomarker of Tubular Oxidative Injury in Patients with Diabetic Nephropathy.

Author Correction: P66shc: A Novel Biomarker of Tubular Oxidative Injury in Patients with Diabetic Nephropathy

Author Correction: A Comprehensive Bioinformatics Analysis on Multiple Gene Expression Omnibus Datasets of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Correction To: Emerging Role of Lipid Metabolism Alterations in Cancer Stem Cells

Author Correction: Pharmacokinetics, mass balance, and metabolism of [ 14 C]vicagrel, a novel irreversible P2Y 12 inhibitor in humans

Corrigendum to “FUNDC1 Insufficiency Sensitizes High Fat Diet Intake-Induced Cardiac Remodeling and Contractile Anomaly Through ACSL4-mediated Ferroptosis” [metabolism 122 (september 2021) 154840]

[Corrigendum] Exosomal microRNA‑4516, microRNA‑203 and SFRP1 are potential biomarkers of acute myocardial infarction

Author correction to ‘Ablation of Akt2 and AMPKα2 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy’ [Acta Pharmaceutica Sinica B 11 (2021) 3508–3526]

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Large-scale, comprehensive plasma metabolomic analyses reveal potential biomarkers for the diagnosis of early-stage coronary atherosclerosis

Corrigendum: Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease